Colloid cyst are cystic lesions in the third ventricle and could render patients asymptomatic. However, there is an inherent risk of symptomatic progression, acute decompensation, and sudden death. Therefore, there is no clear consensus as how to observe or when to treat a newly diagnosed patient with a colloid cyst. The authors' objective is to identify the risk factors and then develop a risk stratification score to guide neurosurgeons during acute or chronic presentation. Radiological imaging characteristics have been outlined for the risk stratification as well preoperative evaluation. A baseline neuropsychological evaluation is helpful to obtain during an incidental presentation because history and neurological examination could be inconclusive in these cases. Radiological imaging with an MRI brain scan plays a vital role for the initial screening (determination of the cyst size, exact location, and the imaging characteristics) as well as for the preoperative planning. Stereotactic guidance is a high yield, followed by neuroendoscopic resection of the colloid cyst has been an established approach to resect these lesions. Modified colloid cyst risk scoring (mCCRS) system is robust and detailed for the optimal risk stratification of colloid cyst presentation. Stereotactic guided neuroendoscopic resection of the colloid cyst is a safe and efficacious approach to manage these lesions. The intended use, crucial steps involved, and the limitations of the technique have been discussed especially with a focus on the recurrence. Moreover, a comprehensive treatment algorithm has been presented.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jocn.2019.12.017 | DOI Listing |
J Neurosurg Case Lessons
December 2024
Department of Neurosurgery, University Medicine Greifswald, Greifswald, Germany.
Background: Colloid cysts (CCs) are benign lesions commonly located in the third ventricle, near the foramen of Monro. They constitute about 0.5%-1% of all intracranial tumors.
View Article and Find Full Text PDFWorld Neurosurg
November 2024
Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Thandalam, Tamil Nadu, India. Electronic address:
World Neurosurg
December 2024
Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India. Electronic address:
Objective: To examine recurrence rates in patients undergoing microsurgical excision of colloid cysts of the third ventricle with long-term serial clinical and imaging follow-up and to identify risk factors for cyst recurrence.
Methods: In this retrospective study, we analyzed a single-surgeon cohort of 84 patients who underwent microsurgical excision of a third ventricular colloid cyst between 1994 and 2018 and who were followed for at least 12 months after surgery. The primary outcome of interest was recurrence (asymptomatic and symptomatic).
Healthcare (Basel)
October 2024
International Medical Center Hospital, Jeddah 23214, Saudi Arabia.
Stereotact Funct Neurosurg
September 2024
Gamma Knife Center Cairo, Nasser Institute For Research and Treatment, Cairo, Egypt.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!